Reuben Benjamin
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
The impact of radiotherapy on the therapeutic response of patients treated with CAR T-cell therapy for high-grade lymphoma: a systematic review.
Journal: Leukemia & lymphoma
Published: July 16, 2026
Response-adapted chimeric antigen receptor T cell (CAR-T)-sparing consolidation radiotherapy in high-risk large B-cell lymphoma (LBCL): Results of the prospective RESTART protocol.
Journal: British journal of haematology
Published: April 06, 2026
Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients.
Journal: Blood cancer journal
Published: March 23, 2026
Optimization of a parallel CAR for B-cell lymphoma via ITAM attenuation and target specificity validation.
Journal: Clinical and experimental immunology
Published: January 17, 2026
DOSET: dose optimization with simultaneous efficacy and toxicity evaluation, motivated by a first-in-human phase I CAR T lymphoma trial.
Journal: ESMO open
Published: December 11, 2025
Case Report: CAR-T therapy for relapsed diffuse large B-cell lymphoma in a patient with pre-existing Parkinson's disease-unfolding clinical challenges.
Journal: Frontiers in oncology
Published: December 02, 2025
A roadmap for supporting the development of advanced therapy medicinal products in a European framework.
Journal: The Lancet regional health. Europe
Published: July 03, 2025
Lymphoma-derived extracellular vesicles inhibit CAR T cell function.
Journal: microPublication biology
Published: May 22, 2025
MTV-guided radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T-cell therapy.
Journal: British journal of haematology
Published: April 10, 2025
Are we there yet? CAR-T therapy in multiple myeloma.
Journal: British journal of haematology
Published: August 15, 2024
Last Updated: 09/26/2026